Seasoned private markets executive focused on healthcare and growth-stage investing. Andrew Dziedzic brings operational and investment experience across venture and growth equity, advising portfolio companies on commercial scaling and capital strategy. He has worked across cross-border deals, corporate development and investor relations, with an analytical, growth-oriented investment approach.
Seasoned private markets executive focused on healthcare and growth-stage investing. Andrew Dziedzic brings operational and investment experience across venture and growth equity, advising portfolio companies on commercial scaling and capital strategy. He has worked across cross-border deals, corporate development and investor relations, with an analytical, growth-oriented investment approach.
Combines growth-stage, healthcare-focused capital deployment with an operator-investor mindset, prioritizing scalable commercial models and repeatable unit economics. Targets late-venture to growth equity opportunities where active governance and commercial scaling drive value; employs cross-border deal sourcing and corporate development levers to expand markets and strategic exits. Allocation favors concentrated, conviction-weighted positions with multi-year horizons, disciplined downside protection via milestone-based financing and hands-on portfolio support to accelerate revenue and de-risk commercial execution.
Combines growth-stage, healthcare-focused capital deployment with an operator-investor mindset, prioritizing scalable commercial models and repeatable unit economics. Targets late-venture to growth equity opportunities where active governance and commercial scaling drive value; employs cross-border deal sourcing and corporate development levers to expand markets and strategic exits. Allocation favors concentrated, conviction-weighted positions with multi-year horizons, disciplined downside protection via milestone-based financing and hands-on portfolio support to accelerate revenue and de-risk commercial execution.
| Trades 718 | Longs Won 533/718 74% | Profit Factor 9.24 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $233,308.32 |
| Average Win $76,893.96 | Best Trade (Mar 30) $3.88M | Sharpe Ratio -10.74 |
| Average Loss -$23,979.16 | Worst Trade (Oct 02) -$580,319.44 | Z-Score -8.9 (100%) |
| Commissions $0 | Avg. Trade Length 11m 3w 1d | Expectancy $14,927.81 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 9,901 | 8,911 | 7,921 | 6,931 | 5,941 | 4,950 | 3,960 | 2,970 | 1,980 | 990 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 6,343 | $1.84M | $2.11M | - | $277,925.45 | 15.14% | +0.089% |
ABBV AbbVie Inc. | 5,962 | $1.5M | $1.6M | - | $94,974.4 | 6.33% | +0.681% |
ABT Abbott Laboratories | 4,718 | $428,118 | $464,109.66 | - | $35,991.66 | 8.41% | -1.728% |
ALL Allstate Corporation | 2,847 | $677,415 | $635,848.98 | - | -$41,566.02 | -6.14% | -0.61% |
AMD Advanced Micro Devices, Inc. | 435 | $252,696 | $285,068.55 | - | $32,372.55 | 12.81% | +3.732% |
AMLP Alerian MLP ETF | 8,413 | $436,226 | $448,539.09 | - | $12,313.09 | 2.82% | +0.651% |
AMZN Amazon.com Inc | 1,936 | $461,426 | $496,661.44 | - | $35,235.44 | 7.64% | +2.045% |
ASML ASML Holding N.V. New York Registry Shares | 137 | $272,553 | $251,517.34 | - | -$21,035.66 | -7.72% | -1.289% |
AVEM Avantis Emerging Markets Equity ETF | 10,350 | $998,637 | $997,170.75 | - | -$1,466.25 | -0.15% | -0.326% |
AVLV Avantis U.S. Large Cap Value ETF | 27,674 | $2.52M | $2.56M | - | $33,461.08 | 1.33% | +0.544% |
BND Vanguard Total Bond Market Index Fund | 117,220 | $8.61M | $8.21M | - | -$393,836.29 | -4.58% | +0.243% |
BRK-B Berkshire Hathaway Inc. | 613 | $306,739 | $310,435.47 | - | $3,696.47 | 1.21% | +0.428% |
CAH Cardinal Health Inc. | 1,464 | $347,682 | $341,829.36 | - | -$5,852.64 | -1.68% | +0.159% |
CEG Constellation Energy Corporation | 993 | $246,666 | $297,204.9 | - | $50,538.9 | 20.49% | +11.838% |
CGBL Capital Group Core Balanced ETF | 10,101 | $383,430 | $376,716.79 | - | -$6,713.21 | -1.75% | +0.471% |
CIBR First Trust NASDAQ Cybersecurity ETF | 12,130 | $1.09M | $1.31M | - | $220,077.7 | 20.19% | +1.868% |
CMBS iShares CMBS ETF | 261,927 | $12.74M | $12.36M | - | -$379,778.59 | -2.98% | +0.032% |
COF Capital One Financial Corporation | 1,785 | $358,107 | $349,735.05 | - | -$8,371.95 | -2.34% | +0.405% |
COWZ Pacer US Cash Cows 100 ETF | 7,775 | $483,628 | $528,000.25 | - | $44,372.25 | 9.17% | +0.355% |
CUSD CrossingBridge Ultra-Short Duration Fund | 91,765 | $1.78M | $1.78M | - | $911.47 | 0.05% | -0.026% |